alss

Conclusion The key that the ALSS is completed successfully is that nurses can operate skillfully , nurse the patient psychologically before the opera - tion and observe the patient carefully during the operation .

结论人工肝支持系统治疗重型肝炎成功的关键是熟练掌握操作技能并做好术前心理护理、术中密切观察患者。

Support ? The protective factor was ALSS .

人工肝支持是保护因素。

Results ALSS therapy achieved a remarkable improvement in clinical symptoms and physical signs .

结果44例肝衰竭患者，经ALSS治疗后临床症状及体征明显改善；

Methods : Analyse the 99 severe hepatitis patients ' complications caused by using ALSS .

方法：分析ALSS治疗99例重型肝炎时并发症的情况。

Besides , ALSS is safe , and it can improve cure rate .

ALSS可提高~（131）I治疗的治愈率和安全性。

ChE of chronic severe hepatitis and improvement rate significantly increased after treatment of ALSS .

ALSS治疗可显著升高慢性重型肝炎ChE值，并提高好转率。血清ChE可作为ALSS治疗后的预后判断指标之一。

Clinical value of MELD and CTP score for evaluation of ALSS in severe hepatitis

MELD评分与CTP分级在人工肝治疗重型肝炎中的价值研究

Conclusion ALSS plays a positive role in treatment of liver failure by removing blood toxins , NO and cytokines .

结论ALSS通过全面清除肝衰竭患者体内毒素、NO和细胞因子，对肝衰竭有肯定的治疗作用；

This paper discussed the operation and nursing care in the treatment of hepatic failure with the Artificial Liver Support System ( ALSS ) .

本文讨论了运用人工肝支持系统治疗重型肝炎中的操作和护理。

Objective To estimate the clinical value of combination of PFA with ALSS in the treatment of SHB .

目的评估膦甲酸钠联合人工肝支持系统治疗重型乙型肝炎的临床价值。

Artificial Liver Support System ( ALSS ) with Choice Membrane Plasma Separator Plus Plasma Specific Bilirubin Adsorption for The Patients With Sever Hepatitis

选择性血浆分离器对胆红素吸附治疗重型肝炎的临床研究

Objective In order to observe the effect of artificial liver support system ( ALSS ) and the factors influencing the therapeutic results in the treatment of severe hepatitis .

目的探讨人工肝体外支持系统在重型肝炎治疗中的疗效及其影响疗效的因素。

Objective To investigate the curative effect of artificial livers support system ( ALSS ) in patients with hepatitis severe and methods of decreasing the adverse reactions .

目的探讨应用人工肝支持系统（ALSS）治疗重型肝炎的疗效及减少ALSS不良反应的方法。

Objective To discuss the experience of application of artificial liver support system ( ALSS ) during perioperative period of orthotopic liver transplantation ( OLT ) .

目的探讨人工肝脏支持系统（artificialliversupportsystem，ALSS）应用于人体原位肝移植围手术期的经验体会。

Treating with nucleosides plus ALSS could accelerate the amelioration of liver function , shorten course of disease , decrease mortality and HBV DNA level .

核苷类似物联合人工肝治疗可加快肝功能好转，缩短病程，降低病死率，降低血清HBVDNA水平。

Conclusion It demonstrates that the MELD and CTP score are useful in predicting the therapeutic effectiveness of ALSS in severe hepatitis .

结论MELD评分与CTP分级评价系统在人工肝治疗重型肝炎中有预测作用。

Objective To evaluate effect of artificial liver support system ( ALSS ) on blood procalcitonin ( PCT ) level and clinical prognosis in patients with hepatitis gravis .

目的通过观察人工肝支持系统对重型肝炎血清降钙素原（PCT）水平的影响，探讨PCT水平改变对重型肝炎临床转归的影响。

Condusions By using common hemodialysis machine , ALSS treatment for chronic fulminant viral hepatitis can alleviate the organ damage and improve the clinical curative rate .

结论利用普通血液透析机进行人工肝（血浆置换联合血液透析）治疗慢性重型肝炎操作方便，治疗安全、有效；

It was indicated that the different susceptibility of ALSs to some inhibitors was one of the reasons of different behave of different plant to these inhibitors in the field .

结果表明，不同植物对某些ALS抑制剂田间表现存在差异，不同植物ALS对这些ALS抑制剂敏感性差别是造成这种差异的原因之一。

Artificial liver support system ( ALSS ) is an assistant device in the treatment of liver failure . It can substitute the functions of the liver by extracorporeal support .

人工肝支持系统（artificialliversupportsystem，ALSS）是目前应用较广、疗效肯定的肝衰竭辅助治疗手段。

Moreover , the efficacy of ALSS treatment in the different stages of hepatitis gravis was investigated . Synchronization of Oestrus in Sheep using P 4 + PG

比较重型肝炎不同期应用ALSS治疗效果。绵羊同期发情

Objective To clinically evaluate the treatment with artificial liver support system ( ALSS ) in combination with plasma exchange and hemodialysis in chronic fulminant viral hepatitis using common hemodialysis machine .

目的探讨利用普通血液透析机进行人工肝（血浆置换联合血液透析）治疗慢性重型肝炎的临床疗效。

Gastrointestinal bleeding occurred in one case at the end of MARS treatment . Conclusion ALSS can improve clinical symptoms and biochemical markers in severe hepatitis patients with the increased survival rate .

结论人工肝支持系统能显著改善慢性乙型重型肝炎患者临床症状及生化指标，提高近期存活率。

Objective : To study the practical use of model end-stage liver disease ( MELD ) on clinic and the role of artificial liver support system ( ALSS ) on end-stage liver disease .

目的通过观察终末期肝病模型（MELD）在终末期肝病预后预测中的作用，探讨其在临床的应用价值及人工肝支持系统在终末期肝病治疗中的效果。

It alss shows that , without new original information , the separability of features could be improved with appropriate optimization method , so that the probablity to recognize patterns of motions can be improved .

结论表明，在没有增加原始信息的情况下，通过合适的特征优化处理可提高特征的可分性，从而提高动作模式的辨识率。

After 8 weeks of treatment , the circumference of abdomen , dyspnea , appetite and crura edema in the control group had an aggravating trend from the ALSS group .

两组病例腹围、呼吸困难、食欲、下肢水肿，在治疗后8周，对照组较人工肝有加重的变化趋势；

Objective This paper , based on the practice , discussed some problems and experiences in the plasma exchange operation of treating children with the KM 8800 , an Artificial Liver Support System ( ALSS ) imported from Japan .

目的：本文从实践出发，讨论了运用日本进口的型号为KM-8800人工肝支持系统进行血浆置换术治疗儿童患者的一些问题和操作体会。

Objectives To explore the therapeutic effects and applications of artificial liver support system ( ALSS ) about plasma exchange ( PE ), plasma absorption ( PA ) combined with plasma exchange on patients with severe hepatitis .

目的探讨人工肝支持治疗（ALSS）-血浆置换（PE）、血浆置换联合血浆吸附（PA）治疗重型肝炎的疗效、时机、可行性。

Results : the ALSS group have treated 124 tis with ALSS , including PE 23 times , CHDF 15 times , PE + CHDF 26 times and MARS 60 times .

结果：人工肝组共进行124次治疗，其中血浆置换23次，CHDF15次，PE+CHDF26例次，MARS治疗60例次。

The curative effect on chronic sever hepatitis in early period was the best after treatment of ALSS , the improvement rate was 81.8 % , and 68.4 % in middle period , and 17.9 % in later period .

ALSS治疗对慢性重型肝炎早期疗效最佳，好转率达81.8%，而中、晚期为68.4%、17.9%。